Search by Drug Name or NDC

    NDC 68462-0678-10 lacosamide 50 mg/1 Details

    lacosamide 50 mg/1

    lacosamide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc. USA. The primary component is LACOSAMIDE.

    Product Information

    NDC 68462-0678
    Product ID 68462-678_a65056ce-b6e9-4bed-adbd-98052a2e705e
    Associated GPIs 72600036000320
    GCN Sequence Number 064432
    GCN Sequence Number Description lacosamide TABLET 50 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14338
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name lacosamide
    Proprietary Name Suffix n/a
    Non-Proprietary Name lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name LACOSAMIDE
    Labeler Name Glenmark Pharmaceuticals Inc. USA
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA205006
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0678-10 (68462067810)

    NDC Package Code 68462-678-10
    Billing NDC 68462067810
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (68462-678-10)
    Marketing Start Date 2022-03-18
    NDC Exclude Flag N
    Pricing Information N/A